STATCenter·
STAT+: Democrats press White House on who got special access to Eli Lilly’s new obesity drug
The unusual access to an experimental drug has captured the attention of the American public as well.
Read at STAT →
The unusual access to an experimental drug has captured the attention of the American public as well.

<iframe src="https://statesidedaily.com/embed/cluster/81c8144c26804f91a3c993ddc3eb0b7b3917c8e7" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: Democrats press White House on who got special access to Eli Lilly’s new obesity drug"></iframe>